Relapsed Diffuse Large B-Cell Lymphoma: Clinical Utility of Cell of Origin

被引：5
|
作者：
Vose, Julie M. [1 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE 68198 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 31期
关键词：
TISSUE MICROARRAY; GERMINAL CENTER; SURVIVAL; IMMUNOHISTOCHEMISTRY; CHEMOTHERAPY; RITUXIMAB; SUBTYPES; IMPROVES;
D O I：
10.1200/JCO.2011.37.5733
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4065 / 4066
页数：2
相关论文
共 50 条
  • [31] Primary Cerebral Diffuse Large B-cell Lymphoma Relapsed Solely in the Skin With the Same Clonal Origin
    Chuang, Shih-Sung
    Liu, Hongxiang
    Huang, Yuanxue
    Chio, Chung-Ching
    Lin, Li-Ching
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2009, 17 (01) : 77 - 81
  • [32] Diffuse large B-cell lymphoma
    Barraclough, Allison
    Hawkes, Eliza
    Sehn, Laurie H.
    Smith, Sonali M.
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (06)
  • [33] Complexity Made Simple in Diffuse Large B-Cell Lymphoma
    Aster, Jon
    Kutok, Jeffery
    CLINICAL CANCER RESEARCH, 2009, 15 (17) : 5291 - 5293
  • [34] Systematic review of therapy used in relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma
    Galaznik, Aaron
    Huelin, Rachel
    Stokes, Michael
    Guo, Yelan
    Hoog, Meredith
    Bhagnani, Tarun
    Bell, Jill
    Shou, Yaping
    FUTURE SCIENCE OA, 2018, 4 (07):
  • [35] Impact of Cell of Origin Classification on Survival Outcomes after Autologous Transplantation in Relapsed/Refractory Diffuse Large B Cell Lymphoma
    Joseph, Jacinth
    Ma, Junsheng
    Hennawy, Fady
    Abdulrazzaq, Mustafa Nooruldeen
    Saini, Neeraj
    Patel, Romil D.
    Hosing, Chitra M.
    Alousi, Amin M.
    Anderlini, Paolo
    Popat, Uday R.
    Qazilbash, Muzaffar H.
    Shpall, Elizabeth J.
    Srour, Samer
    Kebriaei, Partow
    Bashir, Qaiser
    Nastoupil, Loretta J.
    Westin, Jason R.
    Rondon, Gabriela
    Champlin, Richard E.
    Andersson, Borje S.
    Nieto, Yago
    Muzzafar, Tariq
    Ahmed, Sairah
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 404.e1 - 404.e5
  • [36] Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the OncoCollect Lymphoma Registry
    Nair, Reena
    Bhurani, Dinesh
    Rajappa, Senthil
    Kapadia, Asha
    Reddy Boya, Rakesh
    Sundaram, Subramanian
    Menon, Hari
    Raman, Ganapathi S.
    Seshachalam, Arun
    Nimmagadda, Ramesh
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [37] Pathological and clinical diversity in diffuse large B-cell lymphoma
    Piris, Miguel A.
    HEMATOLOGICAL ONCOLOGY, 2013, 31 : 23 - 25
  • [38] Loncastuximab Tesirine in the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Juarez-Salcedo, Luis Miguel
    Nimkar, Santosh
    Corazon, Ana Maria
    Dalia, Samir
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (14)
  • [39] Costs of relapsed diffuse large B-cell lymphoma among Medicare patients
    Huntington, Scott
    Keshishian, Allison
    McGuire, Michael
    Xie, Lin
    Baser, Onur
    LEUKEMIA & LYMPHOMA, 2018, 59 (12) : 2880 - 2887
  • [40] Thalidomide therapy in relapsed diffuse large B-cell lymphoma in elderly patients
    Nikolett, Wohner
    Gergely, Varga
    Peter, Szloboda
    Peter, Farkas
    Andras, Masszi
    Laura, Horvath
    Gergely, Szombath
    Judit, Varkonyi
    Szabolcs, Benedek
    Tamas, Masszi
    ORVOSI HETILAP, 2017, 158 (41) : 1642 - 1648
12345